(BG) Bunge - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: CH1300646267
Stock: Soybean Products, Oilseeds, Grains, Milling
Total Rating 62
Risk 67
Buy Signal 0.29
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | -8.02% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.69 |
| Alpha | 58.16 |
| Character TTM | |
|---|---|
| Beta | 0.196 |
| Beta Downside | 1.139 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.82% |
| CAGR/Max DD | 0.30 |
EPS (Earnings per Share)
Revenue
Description: BG Bunge March 05, 2026
Bunge Global SA (BG) is an agribusiness and food company with global operations.
The companys business model centers on processing and merchandising agricultural commodities. This involves purchasing, storing, transporting, processing, and selling soybeans, softseeds, and other oilseeds. These products serve the food, animal feed, and biofuel industries, reflecting the broad utility of agricultural outputs.
BG also operates in grain merchandising and milling, handling commodities such as corn, wheat, and barley. This segment includes milling operations and related services like ocean freight, highlighting the integrated nature of global commodity supply chains. Investors seeking further insights into BGs financial performance and industry standing may find additional data on ValueRay useful.
Headlines to watch out for
- Global crop yields impact grain merchandising revenue
- Soybean and softseed processing margins drive profitability
- Commodity price volatility affects trading performance
- Biofuel demand influences processing segment growth
- Geopolitical events disrupt agricultural supply chains
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 816.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.44 > 1.0 |
| NWC/Revenue: 13.17% < 20% (prev 16.05%; Δ -2.88% < -1%) |
| CFO/TA 0.02 > 3% & CFO 834.0m > Net Income 816.0m |
| Net Debt (15.82b) to EBITDA (2.46b): 6.42 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (195.0m) vs 12m ago 39.66% < -2% |
| Gross Margin: 4.85% > 18% (prev 0.06%; Δ 478.3% > 0.5%) |
| Asset Turnover: 202.6% > 50% (prev 213.3%; Δ -10.70% > 0%) |
| Interest Coverage Ratio: 2.81 > 6 (EBITDA TTM 2.46b / Interest Expense TTM 628.0m) |
Altman Z'' 3.18
| A: 0.21 (Total Current Assets 24.39b - Total Current Liabilities 15.13b) / Total Assets 44.53b |
| B: 0.30 (Retained Earnings 13.15b / Total Assets 44.53b) |
| C: 0.05 (EBIT TTM 1.76b / Avg Total Assets 34.71b) |
| D: 0.49 (Book Value of Equity 13.15b / Total Liabilities 27.11b) |
| Altman-Z'' Score: 3.18 = A |
Beneish M -2.29
| DSRI: 1.07 (Receivables 3.87b/2.74b, Revenue 70.33b/53.11b) |
| GMI: 1.32 (GM 4.85% / 6.39%) |
| AQI: 1.27 (AQ_t 0.14 / AQ_t-1 0.11) |
| SGI: 1.32 (Revenue 70.33b / 53.11b) |
| TATA: -0.00 (NI 816.0m - CFO 834.0m) / TA 44.53b) |
| Beneish M-Score: -2.29 (Cap -4..+1) = BBB |
What is the price of BG shares?
As of March 15, 2026, the stock is trading at USD 122.72 with a total of 2,561,565 shares traded.
Over the past week, the price has changed by +6.91%, over one month by +2.38%, over three months by +35.49% and over the past year by +74.72%.
Over the past week, the price has changed by +6.91%, over one month by +2.38%, over three months by +35.49% and over the past year by +74.72%.
Is BG a buy, sell or hold?
Bunge has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy BG.
- StrongBuy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 129.6 | 5.6% |
| Analysts Target Price | 129.6 | 5.6% |
BG Fundamental Data Overview March 14, 2026
P/E Trailing = 23.6174
P/E Forward = 13.4771
P/S = 0.321
P/B = 1.4196
P/EG = 1.3705
Revenue TTM = 70.33b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 2.46b USD
Long Term Debt = 8.83b USD (from longTermDebt, last quarter)
Short Term Debt = 5.93b USD (from shortTermDebt, last quarter)
Debt = 16.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.82b USD (from netDebt column, last quarter)
Enterprise Value = 38.39b USD (22.58b + Debt 16.95b - CCE 1.14b)
Interest Coverage Ratio = 2.81 (Ebit TTM 1.76b / Interest Expense TTM 628.0m)
EV/FCF = 129.7x (Enterprise Value 38.39b / FCF TTM 296.0m)
FCF Yield = 0.77% (FCF TTM 296.0m / Enterprise Value 38.39b)
FCF Margin = 0.42% (FCF TTM 296.0m / Revenue TTM 70.33b)
Net Margin = 1.16% (Net Income TTM 816.0m / Revenue TTM 70.33b)
Gross Margin = 4.85% ((Revenue TTM 70.33b - Cost of Revenue TTM 66.92b) / Revenue TTM)
Gross Margin QoQ = 4.25% (prev 4.80%)
Tobins Q-Ratio = 0.86 (Enterprise Value 38.39b / Total Assets 44.53b)
Interest Expense / Debt = 1.27% (Interest Expense 216.0m / Debt 16.95b)
Taxrate = 25.40% (288.0m / 1.13b)
NOPAT = 1.31b (EBIT 1.76b * (1 - 25.40%))
Current Ratio = 1.61 (Total Current Assets 24.39b / Total Current Liabilities 15.13b)
Debt / Equity = 0.98 (Debt 16.95b / totalStockholderEquity, last quarter 17.37b)
Debt / EBITDA = 6.42 (Net Debt 15.82b / EBITDA 2.46b)
Debt / FCF = 53.44 (Net Debt 15.82b / FCF TTM 296.0m)
Total Stockholder Equity = 13.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.35% (Net Income 816.0m / Total Assets 44.53b)
RoE = 5.98% (Net Income TTM 816.0m / Total Stockholder Equity 13.65b)
RoCE = 7.84% (EBIT 1.76b / Capital Employed (Equity 13.65b + L.T.Debt 8.83b))
RoIC = 5.18% (NOPAT 1.31b / Invested Capital 25.38b)
WACC = 4.20% (E(22.58b)/V(39.53b) * Re(6.64%) + D(16.95b)/V(39.53b) * Rd(1.27%) * (1-Tc(0.25)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 15.18%
[DCF] Terminal Value 80.82% ; FCFF base≈387.2m ; Y1≈254.2m ; Y5≈116.0m
[DCF] Fair Price = N/A (negative equity: EV 3.70b - Net Debt 15.82b = -12.12b; debt exceeds intrinsic value)
EPS Correlation: -72.81 | EPS CAGR: -18.37% | SUE: 0.23 | # QB: 0
Revenue Correlation: 1.23 | Revenue CAGR: 11.35% | SUE: 2.66 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.61 | Chg7d=+0.000 | Chg30d=-0.359 | Revisions Net=-3 | Analysts=8
EPS current Year (2026-12-31): EPS=8.12 | Chg7d=-0.008 | Chg30d=-0.822 | Revisions Net=-5 | Growth EPS=+7.2% | Growth Revenue=+29.0%
EPS next Year (2027-12-31): EPS=9.91 | Chg7d=-0.025 | Chg30d=-0.436 | Revisions Net=+0 | Growth EPS=+22.1% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 7.9% - Earnings Yield 4.2%)
[Growth] Growth Spread = +76.0% (Analyst 79.8% - Implied 3.7%)
P/E Forward = 13.4771
P/S = 0.321
P/B = 1.4196
P/EG = 1.3705
Revenue TTM = 70.33b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 2.46b USD
Long Term Debt = 8.83b USD (from longTermDebt, last quarter)
Short Term Debt = 5.93b USD (from shortTermDebt, last quarter)
Debt = 16.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.82b USD (from netDebt column, last quarter)
Enterprise Value = 38.39b USD (22.58b + Debt 16.95b - CCE 1.14b)
Interest Coverage Ratio = 2.81 (Ebit TTM 1.76b / Interest Expense TTM 628.0m)
EV/FCF = 129.7x (Enterprise Value 38.39b / FCF TTM 296.0m)
FCF Yield = 0.77% (FCF TTM 296.0m / Enterprise Value 38.39b)
FCF Margin = 0.42% (FCF TTM 296.0m / Revenue TTM 70.33b)
Net Margin = 1.16% (Net Income TTM 816.0m / Revenue TTM 70.33b)
Gross Margin = 4.85% ((Revenue TTM 70.33b - Cost of Revenue TTM 66.92b) / Revenue TTM)
Gross Margin QoQ = 4.25% (prev 4.80%)
Tobins Q-Ratio = 0.86 (Enterprise Value 38.39b / Total Assets 44.53b)
Interest Expense / Debt = 1.27% (Interest Expense 216.0m / Debt 16.95b)
Taxrate = 25.40% (288.0m / 1.13b)
NOPAT = 1.31b (EBIT 1.76b * (1 - 25.40%))
Current Ratio = 1.61 (Total Current Assets 24.39b / Total Current Liabilities 15.13b)
Debt / Equity = 0.98 (Debt 16.95b / totalStockholderEquity, last quarter 17.37b)
Debt / EBITDA = 6.42 (Net Debt 15.82b / EBITDA 2.46b)
Debt / FCF = 53.44 (Net Debt 15.82b / FCF TTM 296.0m)
Total Stockholder Equity = 13.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.35% (Net Income 816.0m / Total Assets 44.53b)
RoE = 5.98% (Net Income TTM 816.0m / Total Stockholder Equity 13.65b)
RoCE = 7.84% (EBIT 1.76b / Capital Employed (Equity 13.65b + L.T.Debt 8.83b))
RoIC = 5.18% (NOPAT 1.31b / Invested Capital 25.38b)
WACC = 4.20% (E(22.58b)/V(39.53b) * Re(6.64%) + D(16.95b)/V(39.53b) * Rd(1.27%) * (1-Tc(0.25)))
Discount Rate = 6.64% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 15.18%
[DCF] Terminal Value 80.82% ; FCFF base≈387.2m ; Y1≈254.2m ; Y5≈116.0m
[DCF] Fair Price = N/A (negative equity: EV 3.70b - Net Debt 15.82b = -12.12b; debt exceeds intrinsic value)
EPS Correlation: -72.81 | EPS CAGR: -18.37% | SUE: 0.23 | # QB: 0
Revenue Correlation: 1.23 | Revenue CAGR: 11.35% | SUE: 2.66 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.61 | Chg7d=+0.000 | Chg30d=-0.359 | Revisions Net=-3 | Analysts=8
EPS current Year (2026-12-31): EPS=8.12 | Chg7d=-0.008 | Chg30d=-0.822 | Revisions Net=-5 | Growth EPS=+7.2% | Growth Revenue=+29.0%
EPS next Year (2027-12-31): EPS=9.91 | Chg7d=-0.025 | Chg30d=-0.436 | Revisions Net=+0 | Growth EPS=+22.1% | Growth Revenue=+3.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 7.9% - Earnings Yield 4.2%)
[Growth] Growth Spread = +76.0% (Analyst 79.8% - Implied 3.7%)